0000899243-21-038643.txt : 20211001 0000899243-21-038643.hdr.sgml : 20211001 20211001170035 ACCESSION NUMBER: 0000899243-21-038643 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211001 FILED AS OF DATE: 20211001 DATE AS OF CHANGE: 20211001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dainippon Sumitomo Pharma Co Ltd CENTRAL INDEX KEY: 0001446601 STATE OF INCORPORATION: M0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 211299739 BUSINESS ADDRESS: STREET 1: 60 WALL STREET CITY: NEW YORK STATE: NY ZIP: 10005 BUSINESS PHONE: 212-319-7600 MAIL ADDRESS: STREET 1: 60 WALL STREET CITY: NEW YORK STATE: NY ZIP: 10005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sumitomo Chemical Co., Ltd. CENTRAL INDEX KEY: 0001798550 STATE OF INCORPORATION: M0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 211299740 BUSINESS ADDRESS: STREET 1: 27-1, SHINKAWA 2-CHOME STREET 2: CHUO-KU CITY: TOKYO STATE: M0 ZIP: 104-8260 BUSINESS PHONE: 813-5543-5142 MAIL ADDRESS: STREET 1: 27-1, SHINKAWA 2-CHOME STREET 2: CHUO-KU CITY: TOKYO STATE: M0 ZIP: 104-8260 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Roivant Sciences Ltd. CENTRAL INDEX KEY: 0001635088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981173944 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON HM11 STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-295-5950 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2021-10-01 0 0001635088 Roivant Sciences Ltd. ROIV 0001798550 Sumitomo Chemical Co., Ltd. 27-1, SHINKAWA 2-CHOME CHUO-KU, TOKYO M0 104-8260 JAPAN 0 0 1 0 0001446601 Dainippon Sumitomo Pharma Co Ltd 6-8 DOSHOMACHI 2-CHOME CHUO-KU, OSAKA M0 541-0045 JAPAN 0 0 1 0 Common Shares 86367360 I See Footnote Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon") directly owns 86,367,360 Common Shares. Sumitomo Dainippon is a 51.78% owned subsidiary of Sumitomo Chemical Co., Ltd. ("Sumitomo"). Sumitomo may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) the reported securities that Sumitomo Dainippon owns. Sumitomo disclaims beneficial ownership of such reported securities except to the extent of its pecuniary interest therein. Sumitomo Dainippon Pharma Co., Ltd., By: /s/ Tsutomu Nakagawa, Name: Tsutomu Nakagawa, Title: Senior Director, Global Corporate Strategy 2021-10-01 Sumitomo Chemical Co., Ltd., By: /s/ Takeo Kitayama, Name: Takeo Kitayama, Title: Associate Officer, General Manager, Corporate Planning Office 2021-10-01